Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

$19.99

Analysis of Reportable Segments

Microsoft Excel

Paying users area

The data is hidden behind: . Unhide it.

  • Get 1-month access to Abbott Laboratories for $19.99, or

  • get full access to the entire website for at least 3 months from $49.99.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Segment Profit Margin

Abbott Laboratories, profit margin by reportable segment

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Established Pharmaceutical Products
Nutritional Products
Diagnostic Products
Medical Devices

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Segment profitability ratio Reportable segment The company
Segment profit margin Established Pharmaceutical Products Established Pharmaceutical Products segment profit margin ratio deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021.
Nutritional Products Nutritional Products segment profit margin ratio deteriorated from 2019 to 2020 and from 2020 to 2021.
Diagnostic Products Diagnostic Products segment profit margin ratio improved from 2019 to 2020 and from 2020 to 2021.
Medical Devices Medical Devices segment profit margin ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.

Segment Profit Margin: Established Pharmaceutical Products

Abbott Laboratories; Established Pharmaceutical Products; segment profit margin calculation

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Operating earnings
Net sales
Segment Profitability Ratio
Segment profit margin1

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Segment profit margin = 100 × Operating earnings ÷ Net sales
= 100 × ÷ =

Segment profitability ratio Reportable segment The company
Segment profit margin Established Pharmaceutical Products Established Pharmaceutical Products segment profit margin ratio deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021.

Segment Profit Margin: Nutritional Products

Abbott Laboratories; Nutritional Products; segment profit margin calculation

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Operating earnings
Net sales
Segment Profitability Ratio
Segment profit margin1

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Segment profit margin = 100 × Operating earnings ÷ Net sales
= 100 × ÷ =

Segment profitability ratio Reportable segment The company
Segment profit margin Nutritional Products Nutritional Products segment profit margin ratio deteriorated from 2019 to 2020 and from 2020 to 2021.

Segment Profit Margin: Diagnostic Products

Abbott Laboratories; Diagnostic Products; segment profit margin calculation

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Operating earnings
Net sales
Segment Profitability Ratio
Segment profit margin1

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Segment profit margin = 100 × Operating earnings ÷ Net sales
= 100 × ÷ =

Segment profitability ratio Reportable segment The company
Segment profit margin Diagnostic Products Diagnostic Products segment profit margin ratio improved from 2019 to 2020 and from 2020 to 2021.

Segment Profit Margin: Medical Devices

Abbott Laboratories; Medical Devices; segment profit margin calculation

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Operating earnings
Net sales
Segment Profitability Ratio
Segment profit margin1

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Segment profit margin = 100 × Operating earnings ÷ Net sales
= 100 × ÷ =

Segment profitability ratio Reportable segment The company
Segment profit margin Medical Devices Medical Devices segment profit margin ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.

Segment Return on Assets (Segment ROA)

Abbott Laboratories, ROA by reportable segment

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Established Pharmaceutical Products
Nutritional Products
Diagnostic Products
Medical Devices

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Segment profitability ratio Reportable segment The company
Segment ROA Established Pharmaceutical Products Established Pharmaceutical Products segment ROA deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.
Nutritional Products Nutritional Products segment ROA deteriorated from 2019 to 2020 but then improved from 2020 to 2021 not reaching 2019 level.
Diagnostic Products Diagnostic Products segment ROA improved from 2019 to 2020 and from 2020 to 2021.
Medical Devices Medical Devices segment ROA deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.

Segment ROA: Established Pharmaceutical Products

Abbott Laboratories; Established Pharmaceutical Products; segment ROA calculation

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Operating earnings
Total assets
Segment Profitability Ratio
Segment ROA1

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Segment ROA = 100 × Operating earnings ÷ Total assets
= 100 × ÷ =

Segment profitability ratio Reportable segment The company
Segment ROA Established Pharmaceutical Products Established Pharmaceutical Products segment ROA deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.

Segment ROA: Nutritional Products

Abbott Laboratories; Nutritional Products; segment ROA calculation

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Operating earnings
Total assets
Segment Profitability Ratio
Segment ROA1

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Segment ROA = 100 × Operating earnings ÷ Total assets
= 100 × ÷ =

Segment profitability ratio Reportable segment The company
Segment ROA Nutritional Products Nutritional Products segment ROA deteriorated from 2019 to 2020 but then improved from 2020 to 2021 not reaching 2019 level.

Segment ROA: Diagnostic Products

Abbott Laboratories; Diagnostic Products; segment ROA calculation

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Operating earnings
Total assets
Segment Profitability Ratio
Segment ROA1

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Segment ROA = 100 × Operating earnings ÷ Total assets
= 100 × ÷ =

Segment profitability ratio Reportable segment The company
Segment ROA Diagnostic Products Diagnostic Products segment ROA improved from 2019 to 2020 and from 2020 to 2021.

Segment ROA: Medical Devices

Abbott Laboratories; Medical Devices; segment ROA calculation

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Operating earnings
Total assets
Segment Profitability Ratio
Segment ROA1

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Segment ROA = 100 × Operating earnings ÷ Total assets
= 100 × ÷ =

Segment profitability ratio Reportable segment The company
Segment ROA Medical Devices Medical Devices segment ROA deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.

Segment Asset Turnover

Abbott Laboratories, asset turnover by reportable segment

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Established Pharmaceutical Products
Nutritional Products
Diagnostic Products
Medical Devices

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Segment activity ratio Reportable segment The company
Segment asset turnover Established Pharmaceutical Products Established Pharmaceutical Products segment asset turnover ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.
Nutritional Products Nutritional Products segment asset turnover ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.
Diagnostic Products Diagnostic Products segment asset turnover ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.
Medical Devices Medical Devices segment asset turnover ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.

Segment Asset Turnover: Established Pharmaceutical Products

Abbott Laboratories; Established Pharmaceutical Products; segment asset turnover calculation

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Net sales
Total assets
Segment Activity Ratio
Segment asset turnover1

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Segment asset turnover = Net sales ÷ Total assets
= ÷ =

Segment activity ratio Reportable segment The company
Segment asset turnover Established Pharmaceutical Products Established Pharmaceutical Products segment asset turnover ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.

Segment Asset Turnover: Nutritional Products

Abbott Laboratories; Nutritional Products; segment asset turnover calculation

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Net sales
Total assets
Segment Activity Ratio
Segment asset turnover1

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Segment asset turnover = Net sales ÷ Total assets
= ÷ =

Segment activity ratio Reportable segment The company
Segment asset turnover Nutritional Products Nutritional Products segment asset turnover ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.

Segment Asset Turnover: Diagnostic Products

Abbott Laboratories; Diagnostic Products; segment asset turnover calculation

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Net sales
Total assets
Segment Activity Ratio
Segment asset turnover1

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Segment asset turnover = Net sales ÷ Total assets
= ÷ =

Segment activity ratio Reportable segment The company
Segment asset turnover Diagnostic Products Diagnostic Products segment asset turnover ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.

Segment Asset Turnover: Medical Devices

Abbott Laboratories; Medical Devices; segment asset turnover calculation

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Net sales
Total assets
Segment Activity Ratio
Segment asset turnover1

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Segment asset turnover = Net sales ÷ Total assets
= ÷ =

Segment activity ratio Reportable segment The company
Segment asset turnover Medical Devices Medical Devices segment asset turnover ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.

Segment Capital Expenditures to Depreciation

Abbott Laboratories, capital expenditures to depreciation by reportable segment

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Established Pharmaceutical Products
Nutritional Products
Diagnostic Products
Medical Devices

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Segment financial ratio Reportable segment The company
Segment capital expenditures to depreciation Established Pharmaceutical Products Established Pharmaceutical Products segment capital expenditures to depreciation ratio improved from 2019 to 2020 and from 2020 to 2021.
Nutritional Products Nutritional Products segment capital expenditures to depreciation ratio improved from 2019 to 2020 but then slightly deteriorated from 2020 to 2021 not reaching 2019 level.
Diagnostic Products Diagnostic Products segment capital expenditures to depreciation ratio improved from 2019 to 2020 but then deteriorated significantly from 2020 to 2021.
Medical Devices Medical Devices segment capital expenditures to depreciation ratio deteriorated from 2019 to 2020 and from 2020 to 2021.

Segment Capital Expenditures to Depreciation: Established Pharmaceutical Products

Abbott Laboratories; Established Pharmaceutical Products; segment capital expenditures to depreciation calculation

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Additions to property and equipment
Depreciation
Segment Financial Ratio
Segment capital expenditures to depreciation1

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Segment capital expenditures to depreciation = Additions to property and equipment ÷ Depreciation
= ÷ =

Segment financial ratio Reportable segment The company
Segment capital expenditures to depreciation Established Pharmaceutical Products Established Pharmaceutical Products segment capital expenditures to depreciation ratio improved from 2019 to 2020 and from 2020 to 2021.

Segment Capital Expenditures to Depreciation: Nutritional Products

Abbott Laboratories; Nutritional Products; segment capital expenditures to depreciation calculation

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Additions to property and equipment
Depreciation
Segment Financial Ratio
Segment capital expenditures to depreciation1

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Segment capital expenditures to depreciation = Additions to property and equipment ÷ Depreciation
= ÷ =

Segment financial ratio Reportable segment The company
Segment capital expenditures to depreciation Nutritional Products Nutritional Products segment capital expenditures to depreciation ratio improved from 2019 to 2020 but then slightly deteriorated from 2020 to 2021 not reaching 2019 level.

Segment Capital Expenditures to Depreciation: Diagnostic Products

Abbott Laboratories; Diagnostic Products; segment capital expenditures to depreciation calculation

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Additions to property and equipment
Depreciation
Segment Financial Ratio
Segment capital expenditures to depreciation1

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Segment capital expenditures to depreciation = Additions to property and equipment ÷ Depreciation
= ÷ =

Segment financial ratio Reportable segment The company
Segment capital expenditures to depreciation Diagnostic Products Diagnostic Products segment capital expenditures to depreciation ratio improved from 2019 to 2020 but then deteriorated significantly from 2020 to 2021.

Segment Capital Expenditures to Depreciation: Medical Devices

Abbott Laboratories; Medical Devices; segment capital expenditures to depreciation calculation

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Additions to property and equipment
Depreciation
Segment Financial Ratio
Segment capital expenditures to depreciation1

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Segment capital expenditures to depreciation = Additions to property and equipment ÷ Depreciation
= ÷ =

Segment financial ratio Reportable segment The company
Segment capital expenditures to depreciation Medical Devices Medical Devices segment capital expenditures to depreciation ratio deteriorated from 2019 to 2020 and from 2020 to 2021.

Net sales

Abbott Laboratories, net sales by reportable segment

US$ in millions

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Established Pharmaceutical Products
Nutritional Products
Diagnostic Products
Medical Devices
Total reportable segments
Other
Total

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).


Operating earnings

Abbott Laboratories, operating earnings by reportable segment

US$ in millions

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Established Pharmaceutical Products
Nutritional Products
Diagnostic Products
Medical Devices
Total reportable segments
Total

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).


Depreciation

Abbott Laboratories, depreciation by reportable segment

US$ in millions

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Established Pharmaceutical Products
Nutritional Products
Diagnostic Products
Medical Devices
Total reportable segments
Other
Total

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).


Additions to property and equipment

Abbott Laboratories, additions to property and equipment by reportable segment

US$ in millions

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Established Pharmaceutical Products
Nutritional Products
Diagnostic Products
Medical Devices
Total reportable segments
Other
Total

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).


Total assets

Abbott Laboratories, total assets by reportable segment

US$ in millions

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Established Pharmaceutical Products
Nutritional Products
Diagnostic Products
Medical Devices
Total reportable segments
Total

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).